2 terminated, 1 completed, 1 unknown. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
| Not applicable | 1 | Unknown 1 |
Follow Andros Day Surgery Clinic: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility Resveratrol-based multivitamin supplement, Folic acid, IVF/ICSI - Unexplained Infertility | Not applicable | Unknown | Andros Day Surgery Clinic | 90 | 2024-06-01 | 2024-07-01 |
| Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response 150 IU of HMG in patients with age ≤ 35 years, 225 IU of HMG in patients with age > 35 years - Ovarian Response | Completed | Andros Day Surgery Clinic | 160 | 2019-09-20 | 2023-02-01 | |
| Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization | Phase 4 | Terminated | Andros Day Surgery Clinic | 60 | 2016-12-20 | 2020-01-10 |
| Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles rFSH, buserelin - In Vitro Fertilization, Ovarian Stimulation | Phase 4 | Terminated | Andros Day Surgery Clinic | 194 | 2013-03-01 | 2016-12-23 |
Infertility (1)
follitropin alfa (2) · Aging (1) · Buserelin (1) · Fertilization in Vitro (1) · Folic Acid (1) · Injections, Subcutaneous (1) · Progesterone (1) · Triptorelin Pamoate (1) · cetrorelix (1) · ganirelix (1)
Italy (4)
PMID 17222700, PMID 26315293, PMID 28755171, PMID 33487442, PMID 34338114, PMID 36483694, PMID 37599566